Julius H. Jacobson II, Professor of Surgery
The Johns Hopkins University School of Medicine
Vice Chair Clinical Operations Emeritus, Dept. of Surgery; Chief Emeritus Div. Vasc Surg; Director of the Vascular Noninvasive Laboratory
The Johns Hopkins Hospital
Baltimore, Maryland
SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
Presenter
SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated And Reimbursed Accordingly
8:44 AM - 8:49 AM
Session Moderator
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Presenter
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Carotid Webs: An Important Etiology Of Devastating Strokes Especially In Young Women: How Should They Be Diagnosed And Treated
7:54 AM - 7:59 AM
Presenter
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Is TCAR Ready To Replace CEA: What About The Clinical Results To Date: What About The Impact Of Clever Marketing: How Will We Find Out
8:48 AM - 8:53 AM
Presenter
SESSION 109: AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS
Shaking Limb Syndrome: What Is Its Symptoms And Why Is It A Good But Uncommon And Overlooked Indication For CEA Or CAS
11:25 AM - 11:30 AM
Moderator
SESSION 14: Frank J. Veith International Society Associate Faculty Program Presentations – Part II & Vena Cava Topics